Profound Medical Announces Third Quarter 2019 Financial Results

TORONTO, Nov. 07, 2019 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging (“MRI”), thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue, today reported financial results for the three and nine months ended September 30, 2019, and provided an update on its operations.